Det blev imidlertid bemærket, at indikationer, arter og dosering i produktresuméerne for nogle af de godkendte produkter var forskellige, og disse skal derfor ændres, så de bringes i overensstemmelse med de indikationer og dosisregimer, der benyttes i miljørisikovurderingen.
However, it was noted that the indications, species and posology in the SPCs of some of the authorised products were different and these therefore need to be amended to bring them in line with the indications and dosing regimens used in the environmental risk assessment.